Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03063476 · ClinicalTrials.gov registry record · Phase 1

The Effect of Acute Lysine Administration on α-aminoadipic Acid (Sub-study)

A Phase 1 study of Healthy, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
Phase 1
Development phase
2
Enrollment target
1
Study location

NCT03063476 is a Phase 1 study of Healthy that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 2 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03063476, a Phase 1 study of Healthy, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
Phase 1
Development phase
2 participants
Enrollment target
1
Study location

Study Summary

This sub-study aims to assess the effect and breakdown of lysine administration, specifically examining whether it leads to increased plasma 2-AAA in healthy humans.

Conditions Studied

Interventions

  • DRUG Normal saline
  • DRUG C-13 labeled Lysine

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2017-03-01
Est. Completion 2017-05-18
Phase Phase 1

What the Registry Record Tells You About NCT03063476

The ClinicalTrials.gov registry entry for NCT03063476 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (100% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Normal saline is the first listed.

NCT03063476 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT03063476 about?

NCT03063476 is a clinical study titled "The Effect of Acute Lysine Administration on α-aminoadipic Acid (Sub-study)". This sub-study aims to assess the effect and breakdown of lysine administration, specifically examining whether it leads to increased plasma 2-AAA in healthy humans.

What is the current status of trial NCT03063476?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2017-03-01. Estimated completion is 2017-05-18.

What conditions does trial NCT03063476 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT03063476?

The interventions under investigation include: Normal saline (DRUG), C-13 labeled Lysine (DRUG).

Who is sponsoring clinical trial NCT03063476?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03063476 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.